KALARIS THERAPEUTICS, INC. Shareholders' Equity
KALARIS THERAPEUTICS, INC. (KLRS) had Shareholders' Equity of $57.67 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-11
- 2026-06-30: Stockholders' Equity Attributable to Parent $57.67M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $68.56M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $78.81M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $41.87M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $57.67M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $68.56M 10-Q · filed 2026-08-11 | |
| 2025-12-31 | $78.81M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $41.87M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $53.12M 10-Q · filed 2026-08-11 | |
| 2025-03-31 | $63.87M 10-Q · filed 2026-08-11 | |
| 2024-12-31 | -$96.62M 10-Q · filed 2026-08-11 | $113.31M 10-K · filed 2025-03-07 |
| 2024-09-30 | -$89.38M 10-Q · filed 2025-11-12 | $121.12M 10-Q · filed 2024-11-12 |
| 2024-06-30 | -$51.53M 10-Q · filed 2025-11-12 | $120.29M 10-Q · filed 2024-08-09 |
| 2024-03-31 | -$47.54M 10-Q · filed 2025-11-12 | $120.44M 10-Q · filed 2024-05-13 |
| 2023-12-31 | -$45.02M 10-K · filed 2026-03-17 | $145.78M 10-K · filed 2024-03-15 |
| 2023-09-30 | $195.33M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $229.11M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $193.53M 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $224.52M 10-K · filed 2025-03-07 | |
| 2022-09-30 | $253.23M 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $158.14M 10-Q · filed 2023-11-02 | |
| 2022-03-31 | $191.68M 10-Q · filed 2023-11-02 | |
| 2021-12-31 | $225.27M 10-K · filed 2024-03-15 | |
| 2021-09-30 | $267.30M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $302.47M 10-Q · filed 2022-11-03 | |
| 2021-03-31 | $330.37M 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $353.06M 10-K · filed 2023-02-15 | |
| 2020-09-30 | $373.90M 10-Q · filed 2021-11-05 | |
| 2020-06-30 | -$71.29M 10-Q · filed 2021-11-05 | |
| 2020-03-31 | -$60.02M 10-Q · filed 2021-11-05 | |
| 2019-12-31 | -$51.50M 10-K · filed 2022-02-10 | |
| 2019-09-30 | -$43.35M 10-Q · filed 2020-11-10 | |
| 2019-06-30 | -$36.65M 10-Q · filed 2020-11-10 | |
| 2019-03-31 | -$32.91M 10-Q · filed 2020-11-10 | |
| 2018-12-31 | -$30.62M 10-K · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |